VC004

· Jiangsu vcare pharmaceutical technology co., LTD

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VC004, covering 2022-12-13 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors [Phase 3]